Roxana-isms Flashcards
First line regimen for severe HIV-induced PAH
Ambrisentan-Riociguat
-start ambrisentan 10mg first, then sequentially riociguat 1.5 then uptitrate
-avoid PDE5s in HIV (interaction with protease inhibitors)
-Ambrisentan better than macitentan
What dose of IV remodulin can switch to orenitram
Uptitrate IV remodulin to 15 ng/kg/min then start orenitram (generally equivalentis 3mg TID)
- vs if starting without inpatient IV initiation need to start at .125mcg TID of orenitram….
Orenitram- when to start orally vs. inpatient for IV initiation
Orally when have time (RV isn’t horrible on echo, symptoms not terrible) clinically to uptitrate oral outpatient
Inpatient IV remodulin initiation, titrate up to 15 ng/kg/min (dose at which start to have some clinical benefit) with
Ideal dose to get up to on IV remodulin before switching and discharging on orenitram
IV to oral treprostinil
15 ng/kg/min of IV remodulin typically comparable (but weight dependent) to around 3 mg orenitram TID
When c/f high output heart failure and need to come down on remodulin
If CI (cardiac index) > 4.1
Brief pathophys description of high output heart failure
High cardiac output with low SVR where elevation in cardiac output exceeds metaolic demand
- low SVR => RAAS activation => fluid overload
2 main buckets: non-iatrogenic causes of high output heart failure
- Mainly vasodilatory effects: obesity, cirrhosis, Av fistula
- Mainly metabolic effects (increased metabolic demand): hyperthryoidism, myeloprofilerative disorders with extramedullary hematopoeisis
Definition of high output heart failure via invasive hemodynamics
No specific cutoff but generally signs/symptoms of heart failure with CO > 8 or CI > 4
PFT parameter (ratio) that can be used to predict PH in pts with ILD
FVC / DLCO > 1.4 (per literature > 1.4, per Sulica > 1.6)
Classically used for scleroderma-PH
PVOD triad of imaging findings
- diffuse GGO (particularly centrilobular)
- septal thickening
- mediastinal lymphadenopathy
^^(signs of post-capillary venous congestion)
PH and pulmonary congestion with no evidence of L. heart dysfunction
-also typically with normal sized pulmonary veins and lef tatrium
Clinical vignette for PVOD
Severe PH with signs of pulmonary congestion without any evidence of L heart disease (no diastolic dysfunction, no LA dilation, no LVH etc)
- classic CT chest findings: centrilobular diffuse GGOs with septal thickening and mediastinal lymphadenopathy
Orenitram max dose
(a) thought to be equivalent IV dose
Orenitram 10mg TID
(a) Remodulin 50 ng/kg/min